| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 29-35, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
J Reifenberger, G Reifenberger, K Ichimura, EE Schmidt, W Wechsler and VP Collins
Department of Neuropathology, Heinrich-Heine-University, Dusseldorf, Germany.
A series of 13 oligodendrogliomas (WHO grade II) and 20 anaplastic oligodendrogliomas (WHO grade III) was studied for gene amplification and expression of the epidermal growth factor receptor gene (EGFR). EGFR gene amplification was found in only one case of anaplastic oligodendroglioma, which additionally showed a deletion/rearrangement at the 5' end of the gene. Northern blot analysis, however, revealed increases of EGFR mRNA expression relative to non-neoplastic control brain in 6 of 13 oligodendrogliomas and 10 of 18 anaplastic oligodendrogliomas. All cases with increased mRNA expression showed strong immunoreactivity for EGFR protein. Our findings thus indicate that increased expression of EGFR mRNA and protein is common in low- grade and high-grade oligodendroglial tumors and in the vast majority of cases is not caused by gene amplification.
This article has been cited by other articles:
![]() |
M. K. Nicholas, R. V. Lukas, N. F. Jafri, L. Faoro, and R. Salgia Epidermal Growth Factor Receptor-Mediated Signal Transduction in the Development and Therapy of Gliomas Clin. Cancer Res., December 15, 2006; 12(24): 7261 - 7270. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Weiss, M. J. Burns, C. Hackett, K. Aldape, J. R. Hill, H. Kuriyama, N. Kuriyama, N. Milshteyn, T. Roberts, M. F. Wendland, et al. Genetic Determinants of Malignancy in a Mouse Model for Oligodendroglioma Cancer Res., April 1, 2003; 63(7): 1589 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hoang-Xuan, J. He, S. Huguet, K. Mokhtari, Y. Marie, M. Kujas, P. Leuraud, L. Capelle, J. Y. Delattre, J. Poirier, et al. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression Neurology, October 9, 2001; 57(7): 1278 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. McLendon, C. J. Wikstrand, M. R. Matthews, R. Al-Baradei, S. H. Bigner, and D. D. Bigner Glioma-associated Antigen Expression in Oligodendroglial Neoplasms: Tenascin and Epidermal Growth Factor Receptor J. Histochem. Cytochem., August 1, 2000; 48(8): 1103 - 1110. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |